Remarkable Responses to Chemoimmunotherapy in Ultra-Rare Urachal Cancer: A Case Series and Reverse Translational Research

Hiroshi Kotani; Shigeki Sato; Kazuyoshi Shigehara; Daisuke Saito; Hiroyuki Sakaguchi; Akihiro Nishiyama; Isao Matsumoto; Atsushi Mizokami; Seiji Yano; Hiroaki Taniguchi

doi:10.1002/mco2.70516

MedComm ›› 2025, Vol. 6 ›› Issue (12) :e70516 DOI: 10.1002/mco2.70516

LETTER

Remarkable Responses to Chemoimmunotherapy in Ultra-Rare Urachal Cancer: A Case Series and Reverse Translational Research

Author information +

History +

PDF

Cite this article

Download citation ▾

Hiroshi Kotani, Shigeki Sato, Kazuyoshi Shigehara, Daisuke Saito, Hiroyuki Sakaguchi, Akihiro Nishiyama, Isao Matsumoto, Atsushi Mizokami, Seiji Yano, Hiroaki Taniguchi. Remarkable Responses to Chemoimmunotherapy in Ultra-Rare Urachal Cancer: A Case Series and Reverse Translational Research. MedComm, 2025, 6(12): e70516 DOI:10.1002/mco2.70516

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Z. Hamilou, S. North, C. Canil, et al., “Management of Urachal Cancer: A Review by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada,” Canadian Urological Association Journal 14, no. 3 (2020): E57–E64.

[2]	A. Puccini, K. Poorman, F. Catalano, et al., “Molecular Profiling of Signet-Ring-Cell Carcinoma (SRCC) From the Stomach and Colon Reveals Potential New Therapeutic Targets,” Oncogene 41, no. 26 (2022): 3455–3460.

[3]	J. Fucikova, E. Becht, K. Iribarren, et al., “Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates With Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis,” Cancer Research 76, no. 7 (2016): 1746–1756.

[4]	Y. Nagumo, T. Kojima, M. Shiga, et al., “Clinicopathological Features of Malignant Urachal Tumor: A Hospital-Based Cancer Registry Data in Japan,” International Journal of Urology 27, no. 2 (2020): 157–162.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.